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Abstract 
Background: Ralstonia genus are gram negative bacillus and includes four bacteria namely Ralstonia picketti, Ral-
stonia Solanacearum, Ralstonia insidiosa and Ralstonia mannitolilytica. These are opportunistic pathogens and cause 
infections in immunocompromised host. The sources of infection are usually contaminated solutions and water. The 
majority of the reported cases are caused by R. picketti. It is very rare cause of neonatal sepsis with less than twenty 
cases reported in literature till date.
Case presentation: A late preterm male infant, Indian race was admitted to the neonatal intensive care unit for 
respiratory distress developing soon after birth. The infant was managed with respiratory support and gradually 
infant improved and diagnosis of transient tachypnea of newborn was made. At age of 84 h of postnatal life, the 
infant developed features of neonatal sepsis and investigations were suggestive of sepsis. The infant was started on 
intravenous antibiotic, multiple vasopressors and steroids. The blood culture showed growth of multi-drug resistant R. 
picketti. The antibiotics were changed as per sensitivity pattern and infant was discharged in good condition and was 
accepting breast feeding at the time of discharge. There was also no other case of R. picketti in the nursery during the 
same time period.
Conclusion: Ralstonia picketti is an uncommon cause of neonatal sepsis and usually source of infection are con-
taminated solutions and medical products. The management involves early detection, treatment with appropriate 
antibiotics and doing surveillance culture to identify the possible source of infection.
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Introduction
Ralstonia was first isolated in 1973 and was included in 
the genus Pseudomonas spp. Subsequently, this microor-
ganism was reclassified into the genus Burkholderia (Bur-
kholderia picketti and Burkholderia solanacearum). The 
genus Ralstonia was named separately in 1995 by Yabu-
uchi et al. [1]. Ralstonia are aerobic gram-negative bacil-
lus, non-fermentative rods found in water and soil. They 
have low-virulence and are associated with nosocomial 
sepsis by health care personal. Ralstonia genus includes 
four bacteria namely Ralstonia picketti, Ralstonia Sola-
nacearum, Ralstonia insidiosa [2] and Ralstonia man-
nitolilytica [3]. The majority of the reported cases are 
caused by R. picketti, but there are very few case report 
of R. picketti infection in neonate. We here report a case 
report of R. picketti in neonate leading to late onset neo-
natal sepsis. The organism was multi-drug resistant and 
the infant was treated with appropriate antibiotics and 
was discharged in good condition.
Case presentation
A late preterm male infant (34 weeks), Indian race hav-
ing birth weight of 2350 g (appropriate for gestational 
age) was referred for admission to the neonatal inten-
sive care unit (NICU) for respiratory distress develop-
ing soon after birth. The infant was 2 h old at the time of 
admission to the NICU. The infant was born to 24-year 
old primi-gravida mother via normal vaginal delivery. 
The cause of prematurity was preterm labour and there 
were no features of chorioamnionitis in the mother. The 
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clinical examination of the newborn at the time of admis-
sion showed respiratory rate of 68/min, heart rate of 
154 beats/min, capillary refill time of 2 s, audible grunt-
ing with subcostal and intercostal retraction, nasal flar-
ing, normal heart sounds and Silverman Anderson Score 
of 5/10. The infant was started on nasal Bubble CPAP 
(Continuous positive airway pressure) in view of respira-
tory distress and was evaluated with chest radiograph, 
which had features of transient tachypnea of newborn 
(TTNB). The infant was started on intravenous fluid and 
was investigated with sepsis screen. There was gradual 
improvement in respiratory distress in the next 48  h, 
therefore nasal CPAP was removed but the infant had 
minimal oxygen requirement for which oxygen was given 
using nasal prong. The initial blood investigations [total 
leucocyte count, absolute neutrophil count, C-Reactive 
protein (CRP)] were not suggestive of any sepsis there-
fore antibiotics were not started. The infant was started 
on tube feeds and the feeds were gradually increased. At 
age of 84 h of postnatal life, the infant developed features 
of neonatal sepsis (mottling, decreased activity, abdomi-
nal distension, cold and dusky periphery, off colour, 
delayed capillary refill time (>4 s), abdominal distension, 
feed intolerance with altered pre-feed aspirate, low vol-
ume pulses, tachycardia (180–184 beats/min), low blood 
pressure (mean blood pressure 24  mmHg) and tachyp-
nea (respiratory rate  >60/min). The infant was again 
evaluated with total leucocyte count, absolute neutro-
phil count, CRP, blood culture and chest radiograph and 
was started on antibiotic (piperacillin–tazobactum) in 
suspicion of late onset sepsis (LOS). The infant hypoten-
sion was managed with multiple vasopressors and ster-
oids. The investigations showed total leucocyte count of 
3200/microliter (leucopenia), absolute neutrophil count 
876/microliter (moderate neutropenia), platelet count 
of 25,000/microliter (severe thrombocytopenia), Imma-
ture neutrophil/Total neutrophil (I/T) ratio of 0.42, toxic 
granulations on peripheral smear and very high CRP 
(220  mg/l) (normal value  <10  mg/l). Blood gas analysis 
showed mixed acidosis with pH of 7.242, Pco2 46 mmHg, 
bicarbonate 10.2 mmol/l and base excess of −15 mmol/l. 
The chest radiograph showed pneumonia of right lung 
and the infant required invasive ventilation because of 
impending respiratory failure for next 48  h. The infant 
also received packed cell and platelet transfusion for ane-
mia and severe thrombocytopenia. The cerebrospinal 
fluid (CSF) analysis was done in view of LOS, which was 
suggestive of normal study (CSF sugar 84 mg/dl against 
blood sugar of 110 mg/dl, CSF protein being 104 mg/dl 
and cell count showed 02 cells/microliter with 100% cells 
being lymphocytes). The blood culture was send from 
two different site using strict aseptic precaution with 
three swab technique, showed growth of R. picketti. The 
sensitivity pattern of the organism showed sensitivity to 
Tetracycline and Tigecycline, resistance to Cefoperazone 
sulbactum, Ciprofloxacin, Colistin, Amikacin, Amoxy-
clav, Ampicillin, Cefazolin, Cefepime, Cefotaxime, Cef-
tazidime, Cefixime, Ertapenem, Gentamicin, Imipenem, 
Levofloxacin, Meropenam, Piperacillin  +  Tazobactum, 
Piperacillin, Ticarcillin, Trimethoprim/sulfamethoxazole 
and Tobramycin. The CSF culture was not suggestive 
of any bacterial growth. The antibiotics were upgraded 
from piperacillin–tazobactum to Tigecycline as per the 
sensitivity pattern. The clinical condition of the infant 
gradually improved and vasopressors were subsequently 
tapered and stopped. The repeat blood culture sent after 
day 14 of Tigecycline showed no growth. The infant was 
discharged in good condition and was accepting breast 
feeding at the time of discharge. The surveillance cultures 
were sent (hospital water supplies, saline solutions, medi-
cine vials and respiratory therapy equipments) to find the 
source of infection but we were unable to find the source 
of infection in the index case. There was also no case of 
Ralstonia in the nursery during the same time period.
Conclusions
Ralstonia are gram-negative bacillus and rarely causes 
primary bacteremia and the infection is usually second-
ary to contaminated medical products, fluids and/or 
medications. R. picketti (formerly known as Pseudomonas 
picketti and Burkholderia picketti) is most commonly 
reported pathogen for sepsis and has been isolated from 
various clinical specimens like blood, urine and cerebro-
spinal fluid [4], from water including municipal drink-
ing water supplies [5, 6], bottled water [7], dental water 
supplies [8, 9], hospital water supplies [10], space shuttle 
water systems, standard purified water, laboratory based 
high-purity water systems and industrial Ultra-pure/
High Purity water, from plastic industrial water piping, 
medicine vials [11], contaminated saline solution [12], 
from respiratory therapy solutions and wound irrigation 
systems [13], and blood culture bottles [14]. This organ-
ism is not considered as a major pathogen and therefore 
it is not routinely looked for in hospital analysis. Ral-
stonia is an opportunistic human pathogen and seen in 
immunocompromised condition, as seen in the present 
case. The premature neonates are in an immunocompro-
mised state making them prone to develop this infection. 
The recent studies have shown that Ralstonia is a growing 
opportunistic pathogen whole over the world [15].
Ralstonia picketti is an inhabitant of environment, 
is not considered a part of normal human flora and has 
been reported to cause nosocomial outbreak secondary 
to contaminated fluids [16]. Their transmission usually 
requires human contact with heavily contaminated medi-
cal devices or substances encountered in the hospital 
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settings. The exact mode of transmission is not known 
but it likely involves exposure to contaminated medical 
devices. As R. picketti is one of the uncommon cause of 
infection in humans, very little is known about associated 
virulence factors [17].
The microbiological properties show no distinct 
appearance on blood agar and they are non-lactose fer-
menter on Mac Conkey Agar. The biochemical properties 
show variable growth at 42 °C, gas from nitrate and gela-
tin liquefaction, oxidation of lactose, positive for nitrate 
reduction, urea hydrolysis, xylose oxidation and glucose 
oxidation and negative for arginine hydrolysis, Lysine 
decarboxylase and oxidation of mannitol [4].
The treatment of Ralstonia spp. sepsis is difficult and 
challenging because this pathogen is resistant to many 
commonly used antibiotics, like β-lactams and amino-
glycosides [18]. In the index case, the pathogen was only 
sensitive to Tetracycline and Tigecycline. We used Tige-
cycline, a tetracycline derivative as baby condition was 
critically sick and when we assessed risk benefit ratio we 
decided to start Tigecycline and baby improved after the 
change of antibiotics. There is lack of validated suscep-
tibility testing that poses a substantial risk of erroneous 
interpretations. There are no definitive guidelines and 
the reliable therapeutic data is limited as R. picketti is one 
of the rarely isolated organism from human specimens. 
Ryan et al. in their study reported that numerous strains 
of R. picketti and R. insidiosa were highly resistant to the 
aminoglycoside (gentamicin) and the ß-lactam antibiotic 
aztreonam and were variably resistant to the Ticarcillin-
clavulanic acid. The best antibiotic in the study were sul-
famethoxazole/trimethoprim and the fluoroquinolone 
(ciprofloxacin) [19].
There are no recommended vaccination or prophy-
laxis protocols for Ralstonia because of the rarity of the 
infection despite the ubiquity of the organism. Hospital 
acquired infections can be controlled through the use 
of appropriate sterile technique and implementation of 
strict protocols for sterilization and disinfection of hos-
pital supplies [15].
Kimura et  al. conducted case–control study to deter-
mine risk factors for infection following outbreak of 
Ralstonia picketti bacteremia in nursery. There were 18 
patients with 19 episode of infection and all cases were 
within 1 month. There was no neonatal death secondary 
to bacteremia because of low virulence of the bacteria. 
The source of this outbreak was contaminated heparin 
flush and the epidemic ended with discontinuation of it 
[20].
Vitaliti et al. reported a case of neonatal sepsis caused 
by R. picketti in a 26-week infant. The infant had Ralsto-
nia sepsis at 25 days of postnatal life in form of apnea and 
bradycardia requiring mechanical ventilation. The infant 
died secondary to disseminated intravascular coagulation 
and fatal multiorgan failure [21].
Bonatti et al. reported a case of R. picketti in 29-week 
preterm infant. The infant had post-hemorrhagic hydro-
cephalus that was managed with ventriculo–peritoneal 
shunt system and there was isolation of R. picketti from 
the cerebrospinal fluid. This infection was thought sec-
ondary to the shunt and the preterm was discharged in 
well condition [22].
Forgie et al. reported a case of neonate who was oper-
ated for hypoplastic left heart syndrome at age of six day 
of postnatal life. The neonate received extracorporeal 
membrane oxygenation (ECMO) post-operatively and 
neonate developed R. picketti sepsis secondary to ECMO 
circuit. The neonate was treated with ciprofloxacin for 
14 days and was discharged successfully [23].
Pandey et  al. from India reported three case of R. 
picketti bacteremia in adult intensive care unit. The two 
patients succumbed to death were case of leukemia and 
were on immunosuppressive therapy and third case of 
thalassemia, even though on immunosuppressive medi-
cations was discharged successfully [24].
There is need for vigilance over the infection caused by 
Ralstonia especially in intensive care unit where they are 
more prone to cause sepsis. The role of routine antibiotic 
prophylaxis for Ralstonia is not recommended by us as 
the infection is very rare and widespread use of the anti-
biotics may lead to multidrug resistance in this organ-
ism. The health care person should have extra vigilance 
of other patients if a single case of Ralstonia is found 
(e.g. cause could be a contaminated saline solution batch 
or medicine vial) and should test specifically for R. pick-
etti if multiple cases of sepsis suddenly present. There is 
recently an increase in the incidence of Ralstonia sepsis 
and this may be a time for physicians to consider whether 
changes are required to the current norms in prophy-
laxis, detection and/or monitoring.
Ralstonia picketti is not recognized as major pathogen 
and is an uncommon cause of neonatal sepsis. The source 
of infection is usually contaminated solutions and medi-
cal products. The management involves early detection, 
treatment with appropriate antibiotics and doing surveil-
lance culture of the possible sources to identify the cor-
rect source.
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